Applied Nutrition PLC
11 September 2026
Applied Nutrition plc
Director/PDMR Dealing
Applied Nutrition plc (the "Company"), a leading sports nutrition, health and wellness brand, announces the following transactions in the Company's shares. This announcement is made in accordance with Article 19(1) of the EU Market Abuse Regulation as incorporated into UK law through the European Union (Withdrawal) Act 2018.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
|
a) |
Name |
Ryder Holdings Ltd |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
Person Closely Associated with Thomas Ryder, PDMR / Chief Executive Officer |
|||
|
b)
|
Initial notification /Amendment |
Initial notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Applied Nutrition plc |
|||
|
b)
|
LEI |
213800KCP1IDX51ZHE47 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of £0.0002 each |
|||
|
Identification code |
GB00BPVDXX64 |
||||
|
b)
|
Nature of the transaction |
Sale of shares |
|||
|
c) |
Price(s) and volume(s) |
||||
|
Price |
Volume |
||||
|
£2.75 |
4,500,000 |
||||
|
d) |
Aggregated information |
||||
|
- Aggregated volume |
n/a |
||||
|
- Price |
|||||
|
e) |
Date of the transaction |
2026-09-11 |
|||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
|
a) |
Name |
Steven Granite |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
PDMR / Chief Operating Officer |
|||
|
b)
|
Initial notification /Amendment |
Initial notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Applied Nutrition plc |
|||
|
b)
|
LEI |
213800KCP1IDX51ZHE47 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of £0.0002 each |
|||
|
Identification code |
GB00BPVDXX64 |
||||
|
b)
|
Nature of the transaction |
Sale of shares |
|||
|
c) |
Price(s) and volume(s) |
||||
|
Price |
Volume |
||||
|
£2.75 |
2,500,000 |
||||
|
d) |
Aggregated information |
||||
|
- Aggregated volume |
n/a |
||||
|
- Price |
|||||
|
e) |
Date of the transaction |
2026-09-11 |
|||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||
Further information and contacts
|
Applied Nutrition plc |
via Alma |
|
Thomas Ryder, Chief Executive Officer |
|
|
Steven Granite, Chief Operating Officer |
|
|
Joe Pollard, Chief Financial Officer |
|
|
Alma Strategic Communications (Public Relations adviser to Applied Nutrition) |
+44 (0) 203 405 0205 appliednutrition@almastrategic.com |
|
Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.